Impact of GLP-1 Receptor Agonists on Psoriasis and Cardiovascular Comorbidities: A Narrative Review
Psoriasis: Targets and Therapy · 2024-11 · Volume 14 · 143-152
DOI: 10.2147/ptt.s485061 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Psoriasis: Targets and Therapy, 2024-11. Verfasst von Kathryn Haran und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, University of California San Francisco, San Francisco, CA, USA. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, University of California San Francisco, San Francisco, CA, USA.
- Department of Dermatology, Golden State Dermatology, Berkeley, CA, USA.
- Institute for Human Genetics, University of California San Francisco, San Francisco, CA, USA.
ORCID-Profile: Kathryn Haran, Chandler E Johnson, Payton Smith, Allison Kranyak, Tina Bhutani, Wilson Liao
Zitieren
APA
Haran, K., Johnson, C. E., Smith, P., Venable, Z., Kranyak, A., Bhutani, T., Jeon, C., & Liao, W. (2024). Impact of GLP-1 Receptor Agonists on Psoriasis and Cardiovascular Comorbidities: A Narrative Review. Psoriasis: Targets and Therapy, Volume 14, 143-152. https://doi.org/10.2147/ptt.s485061
Vancouver
Haran K, Johnson CE, Smith P, Venable Z, Kranyak A, Bhutani T, et al. Impact of GLP-1 Receptor Agonists on Psoriasis and Cardiovascular Comorbidities: A Narrative Review. Psoriasis: Targets and Therapy. 2024;Volume 14:143-152. doi:10.2147/ptt.s485061
BibTeX
@article{Haran2024,
author = {Haran, Kathryn and Johnson, Chandler E and Smith, Payton and Venable, Zoë and Kranyak, Allison and Bhutani, Tina and Jeon, Caleb and Liao, Wilson},
title = {Impact of GLP-1 Receptor Agonists on Psoriasis and Cardiovascular Comorbidities: A Narrative Review},
journal = {Psoriasis: Targets and Therapy},
year = {2024},
volume = {Volume 14},
pages = {143--152},
doi = {10.2147/ptt.s485061}
}
EUVIMED